Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €362.30 | €421.61 | 16.369% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.85 | €26.01 | 31.048% |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €101.80 | €184.92 | 81.650% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Cytokinetics Inc. | 27 | 1 | 3 | 0 | €58.00 | €85.64 | 47.661% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.06 | €50.33 | 25.643% |
| Icon plc | 18 | 0 | 3 | 0 | €292.80 | €319.67 | 9.177% |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | €39.34 | €41.41 | 5.259% |
| EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 0 | €11.22 | €27.83 | 148.159% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.80 | €20.43 | 73.157% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.01 | €41.10 | 58.028% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.37 | €63.93 | 17272.554% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €139.65 | €236.30 | 69.207% |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €2.04 | €8.39 | 311.492% |
| United Therapeutics | 18 | 0 | 3 | 0 | €245.40 | €288.66 | 17.629% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.16 | €196.74 | 41.374% |
| ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | €1.83 | €3.03 | 65.905% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.12 | €35.43 | 41.040% |
| MacroGenics Inc. | 13 | 1 | 4 | 1 | €3.07 | €14.25 | 363.696% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.20 | €174.43 | 16.913% |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | €21.60 | €45.21 | 109.306% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.21 | €86.77 | 41.760% |